Masson Kristina 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Masson Kristina
DirectorEVP - Business Operations
Transactions
- Tax Payment
Common Stock
2024-02-14$3.40/sh−579$1,969→ 318,226 total
Holdings
- 2,616,812(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- [F2]These securities are held by President and CEO, Peter Blume-Jensen, who is also Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.